Partner Antoinette Konski and Associate Simon Elliott authored, “Induced Pluripotent Stem Cells: A U.S. Patent Landscape Analysis,” published in the May 14, 2013 edition of Genetic Engineering and Biotechnology News. The article provides a discussion of the U.S. patent landscape for induced pluripotent stem cells (iPSCs) and identifies key technologies and institutions that are leading research and development in the creation and use of iPSCs.
The article also was referenced in a May 14, 2013 piece in the Boston Business Journal, which discussed the growth in the number of iPSCs patents held by Cambridge-area companies.
Click here to read the entire article.
Author(s)
Related Insights
July 8, 2025
Tariff & International Trade Resource
Foreign Companies, U.S. Risk: The False Claims Act Can Be a Global Compliance Risk
The Trump Administration’s Department of Justice has made clear that it will aggressively use the False Claims Act as part of its corporate enforcement program.
July 7, 2025
Labor & Employment Law Perspectives
Florida Bucks Trend, Enacts New Employer-Friendly Noncompete Statute
While the recent trend across the country has been to restrict noncompete agreements, Florida has just made it easier for employers to…
July 7, 2025
Health Care Law Today
DOJ-HHS False Claims Act Working Group: Focus on Medicare Payment Suspensions
In a July 2, 2025, press release, the U.S. Department of Justice (DOJ) announced a new “DOJ-HHS False Claims Act Working Group” (the…